Home › Calculator › MRKR Dividend Calculator 2026
MRKR Dividend Calculator 2026
No dividendHealthcareMarker Therapeutics, Inc. · NASDAQ
Price: $0.96 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
MRKR is not a dividend-focused stock
MRKR pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
MRKR Dividend Yield
Marker Therapeutics, Inc. (MRKR) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MRKR pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Marker Therapeutics, Inc. (MRKR) — Dividend Analysis 2026
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary MultiTAA-specific T cell technology. This method involves producing T cells that are not genetically modified but are specifically designed to target tumors. These specialized T cells can identify multiple antigens associated with tumors, allowing them to effectively eliminate cancer cells that express these markers. Marker Therapeutics' MultiTAA-specific T cell therapies encompass patient-derived (autologous) T cells for treating lymphoma and various solid tumors, as well as donor-derived (allogeneic) T cells for acute myeloid leukemia and acute lymphoblastic leukemia. They also provide "off-the-shelf" solutions applicable to a range of diseases. In addition to T cell therapies, the company is advancing peptide-based immunotherapeutic vaccines. This pipeline includes TPIV100/110, developed to combat breast and ovarian cancer cells, and TPIV200, which is currently undergoing Phase 2 clinical trials for the treatment of breast and ovarian cancers. Founded in 1999, Marker Therapeutics maintains its headquarters in Houston, Texas.
MRKR Dividend & DRIP — Frequently Asked Questions
Does MRKR pay a dividend?
No. Marker Therapeutics, Inc. (MRKR) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of MRKR?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does MRKR have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. MRKR has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to MRKR
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MRKR DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MRKR position with:
🌍 MRKR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MRKR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MRKR Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MRKR Dividend Payment Schedule
MRKR pays quarterly — 4 times per year. Ex-div: —.
📊 MRKR vs Healthcare Benchmarks
How MRKR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MRKR sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MRKR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-11-17 | 137,330 | $0.95 | $131.1K | ||
| A-Award | 2025-11-17 | 84,411 | $0.95 | $80.6K | ||
| A-Award | 2025-11-17 | 137,330 | $0.95 | $131.1K | ||
| A-Award | 2025-11-17 | 84,411 | $0.95 | $80.6K | ||
| A-Award | 2025-11-17 | 137,330 | $0.95 | $131.1K | ||
| A-Award | 2025-11-17 | 84,411 | $0.95 | $80.6K | ||
| A-Award | 2025-10-31 | 147,611 | $0.99 | $145.8K | ||
| A-Award | 2025-10-31 | 250,000 | $0.99 | $246.9K | ||
| A-Award | 2025-02-12 | 30,000 | $1.59 | $47.7K | ||
| A-Award | 2025-02-12 | 30,000 | $1.59 | $47.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare MRKR with peers: MRKR vs AEON · MRKR vs BOLT · MRKR vs CLRB
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MRKR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Marker Therapeutics, Inc. (MRKR) is currently trading at $0.96, 61% below its 52-week high. It does not currently pay a regular dividend.
Does MRKR Pay a Dividend? Marker Therapeutics, Inc. Dividend Status
Marker Therapeutics, Inc. (MRKR) is a healthcare stock trading at $0.96. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MRKR News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your MRKR DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.